?. MORE GENETICS OF PK AND PD Lecture #28 Inherited Variability Restricted to drug metabolism ~None with drug absorption, distribution, renal or biliary.

Slides:



Advertisements
Similar presentations
National Cancer Institute Slide Show on Single Nucleotide Polymorphisms [SNPS]
Advertisements

Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy Mark E. Sobel, M.D., Ph.D. Executive Officer American Society for.
Drug/xenobiotic metabolism and pharmacogenetics George Howell III, Ph.D.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Factors Affecting Distribution and Metabolism. Chemical Factors Lipophilicity Structure Ionization Chirality.
New Zealand College of Pharmacists
Javad Jamshidi Fasa University of Medical Sciences, December 2014 Session 8 Medical Genetics Pharmaco genetics.
Absorption, Distribution, Metabolism and Elimination: Part II
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD.
Pharmacogenomics: advancing personalized medicine.
DRUG TREATMENT IN THE ELDERLY. THE BASIC PROBLEM Drug treatment increases (almost exponentially) with age The elderly are presumed to be - because of.
DRUG TREATMENT IN THE ELDERLY
Antimycobacterial drugs By Bohlooli S, PhD School of Medicine, Ardabil University of Medical Sciences.
Drug metabolism Prof. M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General pharmacology.
PHAR 751 Pharmacogenomics Sarah Brown, Pharm.D. Pharmacy Practice Resident Asante Health System
Pharmacotherapy of Gastric Acidity, Peptic Ulcer…
Pharmacogenetics Definitions – Pharmacogenetics: single gene differences among population groups and the effects on pharmacodynamics. – Pharmacegenomics:
Antibiotics and Resistance Prepared by Stephanie Aldret Cell Physiology Fall 2002.
Toxicity Interactions In Anagrams InfectionsPregnancy.
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Phase II: Conjugation Synthetic reaction of a xenobiotic (or of a Phase I metabolite of a xenobiotic) with an endogenous substance Results in introduction.
PHAR 751 Pharmacogenomics
GeneTaqman assayGene function Gene Cards Shp Mm _m1 Small heterodimer protein The protein encoded by this gene is an unusual.
Chapter 10 Opener. Figure 10.1 Metabolic Diseases and Enzymes.
Gene Therapy Clinical Trials. Cancer Gene Therapy Three Basic Approaches. Genetically alter a person's immune cells that are already naturally targeted.
Section 1, Lecture 4 Phase I reactions-oxidative occur in the endoplasmic reticulum of liver (microsomal fractions) - catalyzed by the microsomal.
Are You Ready for Pharmacogenomics? Bruce Matthias June 3, 2010 MUSE International Conference.
Prof. Hanan Hagar Pharmacology Department By the end of this lecture, students should:  Recognize the importance of biotransformation  Know the different.
Pharmacology Department
Introduction & Biomedical importance
?. MORE GENETICS OF PK AND PD Lecture #28 Inherited Variability Restricted to drug metabolism ~None with drug absorption, distribution, renal or biliary.
Holy Family Catholic High School 17th April 2007 Developing medicines + Immunity UNIT 11.4 Controlling infectious disease Form 10 A4.
Lesson Four Structure of a Gene. Gene Structure What is a gene? Gene: a unit of DNA on a chromosome that codes for a protein(s) –Exons –Introns –Promoter.
Clarifications of Lecture #36- Drug Interactions I
DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.
Mistakes can occur in any process. When do mistakes have stronger effects – When making a DNA? Making mRNA? Making a protein? Explain why. (Same as saying.
Chapter 2. Amino acids Protein structure Primary:
AP Biology Mutations Unit 5B.5. AP Biology Changes in genotype (DNA) can result in changes in phenotype  Alterations in DNA sequence can lead to changes.
Nucleotides (molecules containing sugar, nitrogen containing purine and pyrimidine bases, and a phosphate group) are the building blocks of DNA.
Basic Principles: PK By: Alaina Darby.
INTERAKSI OBAT.
IMMUNOSUPPRESSANTS AZATHIOPRINE.
Lesson Four Structure of a Gene.
Nivolumab Drugbank ID : DB09035 Molecular Weight (Daltons) :
Pharmacology Tutoring – Factors Affecting Drug Action
Molecular mechanism of mutation
Lesson Four Structure of a Gene.
Pharmacokinetics.
Drug Elimination Drug elimination consists of 2 processes
Pharmacokinetics.
Mahla sattarzadeh Kerman University of Medical Sciences
IBD: GC, purine analogs and MTX
Figure 4 Activation of clopidogrel via cytochrome P450
Pharmacogenomics in Inflammatory Bowel Disease
Beatriz Pérez González 2017/18 Genomics
Jeopardy Final Jeopardy Unit 1- Unit 2- Unit 3- Unit 4- Lagniape $100
Kinds of Mutations Point Mutation Occur at a single point in the DNA
Conceptual Subdivisions of Pharmacology
Conceptual Subdivisions of Pharmacology
Brian D. Juran, Laurence J. Egan, Konstantinos N. Lazaridis 
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition Zhou F, Zhub L, Wang K, Murray M Advanced Drug Delivery.
Pharmacogenomic variability and anaesthesia
Clinical Pharmacokinetics
Pharmacology 3 Antimycobacterial drugs Lecture 12 By Prof. Dr
Introduction to Pharmacogenetics
Antimetabolites ( Sulfonamides )
Department of Molecular Pharmacology & Neuroscience
Lecture 5 By Prof. dr. Mohammed Fahmy
Presentation transcript:

?

MORE GENETICS OF PK AND PD Lecture #28

Inherited Variability Restricted to drug metabolism ~None with drug absorption, distribution, renal or biliary excretion – Exception: organic anion-transporting polypeptide 1B1 (OATP1B1)  pravastatin

Mutation Types Non-synonymous substitution – alters amino acid of protein synonymous substitution – “silent mutation” and degeneracy – doesn’t alter amino acid

Basic Genetics intron “Between Genes”

Mutation Types Non-synonymous substitution – alters amino acid of protein synonymous substitution – “silent mutation” and degeneracy – doesn’t alter amino acid

Inherited Variability in PK Oxidation – CYP2D6 – CYP2C9 – CYP2C19 – CYP3A S-methylation – Thiopurine methyltransferase (TMPT) Acetylation – N-acetyltranferase (NAT)

Oxidation: CYP2C9

Oxidation: CYP2C19 (PPI)

Oxidation: CYP2C19 Polymorphisms

Oxidation: CYP2C19

CYP2C19: Proton Pump Inhibitor Therapy

Oxidation: CYP3A

Extra Slide

S-methylation: Thiopurine Methyltransferases (TPMT) S-methylation of thiopurine drugs used to treat cancer and as immunosuppressants SAM 6-thioguanine

S-methylation: Reaction 6-thioguanine 6-methylthioguanine TPMT S-adenosyl methionine S-adenosyl-L-homocysteine CH 3 antimetabolites (anticancer drug)

Polymorphisms

S-methylated Drugs Pharmacodynamics HGPRT= Hypoxanthine-guanine phosphoribosyltransferase immunosuppressant (organ tranplantation) cancer, Crohn’s disease and ulcerative colitis Target inhibit cell proliferation

Conventional versus Individualized Individualized Conventional

Acetylation: N-acetyltransferases (NAT) Acetyl-CoA

General Reaction NAT R R

Reactions (Sim, 2008 Toxicology)

Families, Location and General Substrate Specificities NAT1 – everywhere – folate degradation – breast cancer NAT2 – Liver and Gut – sulfamethazine and arylhydrazine – isoniazid induced neurotoxicity and hydralazine- induced lupus (slow metabolizers) sulfamethazine arylhydrazine (Sim, 2008 Toxicology)

Genetics: Polymorphic Variants NAT2NAT1

NAT2 KatG = Bacterial Catalase-peroxidase InhA = Bacterial 2-trans-enoyl-acyl carrier protein reductase tuberculosis antibiotic

NAT2

Metabolic Profiling

Extra